Lymphocyte Immunization Therapy (LIT) in India

Across India, thousands of couples go through the same painful cycle: conception happens, but pregnancies do not continue. Or IVF is attempted with good embryos, and implantation keeps failing. Reports come back normal, and no one can offer a clear explanation. For many of these couples, the cause is not structural or hormonal. It is immunological, and it has simply never been investigated.

ICPRM is one of India's few centres dedicated to this specific dimension of fertility. We offer Lymphocyte Immunization Therapy (LIT) in India as a targeted, evidence-based treatment for couples dealing with immune-related pregnancy failure. Led by Dr. Mohan Raut and Dr. Mugdha Raut, recognized among the best LIT doctors in India, our centre brings a depth of reproductive immunology expertise that is rarely available through conventional fertility care.

What is Lymphocyte Immunization Therapy (LIT)?

Lymphocyte Immunization Therapy (LIT) is an advanced reproductive immunology treatment designed for women experiencing recurrent miscarriages due to immune incompatibility with their partners. The procedure uses the partner's white blood cells, called lymphocytes, which are carefully processed and reintroduced into the woman's body. This helps her immune system learn to recognize and accept the embryo rather than reject it, improving the chances of a successful, sustained pregnancy.

At ICPRM, LIT is not a protocol applied uniformly to every patient. Each couple undergoes a thorough immunological evaluation first, and treatment is recommended only where the clinical evidence supports it. The procedure is performed in sterile, fully equipped clinical facilities by experienced reproductive immunology specialists, with safety and precision at every step.

How Does LIT Help in Pregnancy?

For a pregnancy to succeed, the mother's immune system has to do something that does not come naturally: protect rather than attack cells carrying the father's genetic material. This process is called immune tolerance, and when it fails, the result is often recurrent miscarriage, failed implantation, or unexplained infertility despite normal test results.

Our LIT therapy in India works by introducing carefully processed lymphocytes from the partner into the woman's system. This encourages her body to produce the protective antibodies that support embryo acceptance and implantation. Clinical evidence supports improved pregnancy outcomes for couples who undergo this therapy, particularly in cases where recurrent pregnancy loss has no other clear explanation.

Who Can Benefit from LIT in India?

India's fertility landscape reflects a convergence of factors: rising PCOS rates, delayed family planning, metabolic disorders driven by urban lifestyle changes, environmental stressors, and a healthcare system where immune-related fertility causes are still underdiagnosed. Across the cities where we operate, we see a consistent pattern of couples who have been through significant fertility treatment without resolution, not because the treatment was wrong, but because the immune dimension was never evaluated.

Our LIT treatment in India is relevant for couples dealing with:

Recurrent pregnancy loss with no structural or hormonal explanation: Across India's urban population, immune incompatibility between partners is one of the most commonly missed causes of repeated miscarriage. When standard investigations return normal results and pregnancies continue to fail, LIT offers a clinically grounded next step.

Repeated IVF or IUI failure despite good embryo quality: When embryos are healthy but do not implant, the problem lies with the immune environment of the uterus, not the embryo itself. LIT is designed to correct this by preparing the immune system to accept rather than reject the developing pregnancy.

PCOS-related implantation failure: PCOS is one of the most prevalent fertility conditions in Indian women, and it carries a background of chronic low-grade inflammation that can compromise uterine receptivity. For PCOS patients with repeated cycle failures, an immune evaluation often reveals what hormonal treatment alone has missed.

Secondary infertility after a first successful pregnancy: Couples who have had one child but cannot sustain a second pregnancy are increasingly presenting at our centres. Immune dysregulation, sometimes influenced by metabolic changes or prior infections, can shift the immune response between pregnancies in ways that LIT can address.

Negative lymphocyte crossmatch between partners: Where protective blocking antibodies are absent, the mother's immune system cannot adequately tolerate the embryo. LIT stimulates the production of these antibodies, building the immune foundation that a pregnancy needs to establish and progress.

The ImmuLIT® Treatment Process at ICPRM

From the first conversation to parenthood, the process is structured, clear, and clinically guided at every stage.

1. Online Consultation: Your fertility history, investigation records, and previous treatment outcomes are reviewed in a detailed virtual consultation that forms the foundation of your care plan.
2. Investigations: A targeted reproductive immunology panel is recommended, examining immune markers that standard fertility workups do not routinely include.
3. Single-Sitting 3-Hour ImmuLIT® Procedure: Prepared paternal lymphocytes are administered to the mother in a single outpatient sitting of approximately three hours, with no hospitalisation required.
4. Follow-up: Post-procedure immune monitoring confirms the tolerance response and determines the clinically optimal window for the next conception or embryo transfer attempt.
5. Parenthood: With the immune environment appropriately recalibrated, couples move toward pregnancy with a clinical rationale behind every next step.

Why Choose ICPRM for LIT in India?

ICPRM is recognized as one of the leading LIT hospitals in India, with a clinical focus that is rare in the country's fertility care landscape. Most fertility centres in India are built around the standard IVF model. We are built around the immune dimension of fertility, specifically for the cases that the standard model cannot resolve.

Dr. Mohan Raut and Dr. Mugdha Raut, regarded among the top LIT specialists in India, bring decades of combined experience in reproductive immunology. Every couple who comes to us receives a treatment plan that is built around their specific immune profile, not a generalized protocol. Our approach is evidence-based, our communication is honest, and our focus is always on finding what has actually been missed, not repeating what has already been done.

ICPRM currently operates across six cities in India: Mumbai, Hyderabad, Nagpur, Pune, Bengaluru, and Delhi. Wherever you are in the country, online consultations are available so you can connect with us before arranging an in-person visit at the centre nearest to you.

FAQs

1. Is LIT available across India, or only in select cities?

ICPRM currently offers LIT at centres in Mumbai, Hyderabad, Nagpur, Pune, Bengaluru, and Delhi. Online consultations are available for patients anywhere in India to connect with Dr. Mugdha Raut before their first visit.

2. How do I know if LIT is the right treatment for me?

Suitability for LIT is determined through our immunological evaluation. If you have experienced recurrent miscarriage, repeated IVF failure with good embryo quality, or unexplained infertility despite normal reports, an immune-focused assessment is a clinically appropriate next step. Dr. Raut will review your history and advise honestly on whether LIT is indicated.

3. Is LIT safe?

Yes. LIT is a well-tolerated, minimally invasive procedure conducted in a sterile clinical setting under expert supervision. There are no known serious long-term side effects. Most patients experience only mild, temporary redness at the injection site.

4. How long does the LIT procedure take?

The procedure is completed in a single sitting of approximately three hours. No hospital admission is required.

5. Can LIT be combined with IVF?

Yes. Many of our patients across India combine LIT with IVF or IUI. LIT is typically administered before the planned cycle to prepare the immune environment for implantation. We coordinate the timing with your IVF team to ensure both treatments complement each other.